Drug Type Biological products |
Synonyms |
Target |
Mechanism PRDX5 modulators(peroxiredoxin 5 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization iMetabolic Biopharma Corp.Startup |
Active Organization iMetabolic Biopharma Corp.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipoproteinemia Type I | Discovery | US | iMetabolic Biopharma Corp.Startup | - |